Our mission is to unlock the therapeutic potential of complex and challenging disease targets that are intractable to conventional discovery methods.

We achieve this by using our innovative discovery platform to identify functional Microcycles that modulate targets within their native intracellular environment.

We are using these functional Microcycles to design and develop a pipeline of new small molecule drugs, initially against high priority cancer targets.